Weycker D, Li X, Barron R, Wu H, Morrow PK, Xu H, Reiner M, Garcia J, Mhatre SK, Lyman GH. Importance of risk factors for febrile neutropenia among patients receiving chemotherapy regimens not classified as high-risk in guidelines for myeloid growth factor use. J Natl Compr Canc Netw 2015;13(8):979-86. - PAI - Policy Analysis Inc.

Weycker D, Li X, Barron R, Wu H, Morrow PK, Xu H, Reiner M, Garcia J, Mhatre SK, Lyman GH. Importance of risk factors for febrile neutropenia among patients receiving chemotherapy regimens not classified as high-risk in guidelines for myeloid growth factor use. J Natl Compr Canc Netw 2015;13(8):979-86. - PAI - Policy Analysis Inc.